VYLUMA INC.
Medtech · Private
Topical pregabalin ophthalmic formulation (NVK032) for corneal pain treatment
- Grants
- $295K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 23
- 8 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a safe and effective topically administered pharmacotherapy to treat acute corneal pain | $295,086 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1611 | WR Biotech, LLC | — | — |
| 1612 | Buck Surgical, Inc. | — | $300K |
| 1613 | NeoTherma Oncology Inc. | — | — |
| 1614 | VYLUMA INC. | — | — |
| 1615 | PEAK DIAGNOSTIC PARTNERS LLC | — | — |
| 1616 | Eye To Eye Telehealth, Inc. | — | $1.0M |
| 1617 | PROPEL ORTHODONTICS, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Childhood Atropine For Myopia Progressionapplication
- Atropine Pharmaceutical Compositionsapplication
- Atropine Pharmaceutical Compositionsgranted
- Atropine Pharmaceutical Compositionsgranted
- Multi-Dose Container for Ophthalmic Compositionsapplication
- Methods And Formulations For Topical Administration Of Gabapentinoidsapplication
- Low-Dose Ophthalmic Compositions and Methodsapplication
- Atropine Pharmaceutical Compositionsgranted
- Atropine Pharmaceutical Compositionsgranted
- Atropine Pharmaceutical Compositionsgranted
- Atropine Pharmaceutical Compositionsgranted
- Atropine Pharmaceutical Compositionsgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.